A broad-spectrum macrocyclic peptide inhibitor of the SARS-CoV-2 spike protein

被引:13
|
作者
Thijssen, Vito [1 ,2 ]
Hurdiss, Daniel L. [3 ]
Debski-Antoniak, Oliver J. [3 ]
Spence, Matthew A. [4 ]
Franck, Charlotte [5 ,6 ]
Norman, Alexander [5 ,6 ]
Aggarwal, Anupriya [7 ]
Mokiem, Nadia J. [8 ,9 ]
van Dongen, David A. A. [1 ,8 ,9 ]
Vermeir, Stein W. [1 ,2 ]
Liu, Minglong [1 ,2 ]
Li, Wentao [3 ]
Chatziandreou, Marianthi [3 ]
Donselaar, Tim [3 ]
Du, Wenjuan [3 ]
Drulyte, Ieva [10 ]
Bosch, Berend-Jan [3 ]
Snijder, Joost [8 ,9 ]
Turville, Stuart G. [7 ]
Payne, Richard J. [5 ,6 ]
Jackson, Colin J. [4 ,11 ,12 ]
van Kuppeveld, Frank J. M. [3 ]
Jongkees, Seino A. K. [1 ,2 ]
机构
[1] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Chem Biol & Drug Discovery, NL-3584 CG Utrecht, Netherlands
[2] Vrije Univ Amsterdam, Amsterdam Inst Mol & Life Sci, Chem & Pharmaceut Sci, NL-1081 HV Amsterdam, Netherlands
[3] Univ Utrecht, Fac Vet Med, Dept Biomol Hlth Sci, Sect Virol,Div Infect Dis & Immunol, NL-3584 CL Utrecht, Netherlands
[4] Australian Natl Univ, Res Sch Chem, Canberra, ACT 2601, Australia
[5] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia
[6] Univ Sydney, Australian Res Council, Ctr Excellence Innovat Peptide & Prot Sci, Sydney, NSW 2006, Australia
[7] Kirby Inst, Sydney, NSW 2052, Australia
[8] Univ Utrecht, Bijvoet Ctr Biomol Res, Biomol Mass Spectrometry & Prote, NL-3584 CH Utrecht, Netherlands
[9] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands
[10] Thermo Fisher Sci, Mat & Struct Anal, NL-5651 GG Eindhoven, Netherlands
[11] Australian Natl Univ, Australian Res Council, Ctr Excellence Innovat Peptide & Prot Sci, Canberra, ACT 2601, Australia
[12] Australian Natl Univ, Australian Res Council, Ctr Excellence Synthet Biol, Canberra, ACT 2601, Australia
基金
比尔及梅琳达.盖茨基金会; 荷兰研究理事会; 澳大利亚研究理事会;
关键词
macrocyclic peptides; mRNA display; SARS-CoV-2; antivirals; Cryo-EM; DISCOVERY; APTAMERS; DOMAIN;
D O I
10.1073/pnas.2303292120
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The ongoing COVID-19 pandemic has had great societal and health consequences. Despite the availability of vaccines, infection rates remain high due to immune evasive Omicron sublineages. Broad-spectrum antivirals are needed to safeguard against emerging variants and future pandemics. We used messenger RNA (mRNA) display under a reprogrammed genetic code to find a spike-targeting macrocyclic peptide that inhibits SARS-CoV- 2 (severe acute respiratory syndrome coronavirus 2) Wuhan strain infection and pseudoviruses containing spike proteins of SARS-CoV- 2 variants or related sarbecoviruses. Structural and bioinformatic analyses reveal a conserved binding pocket between the receptor-binding domain, N-terminal domain, and S2 region, distal to the angiotensin-converting enzyme 2 receptor-interaction site. Our data reveal a hitherto unexplored site of vulnerability in sarbecoviruses that peptides and potentially other drug-like molecules can target.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] FOUR POTENTIAL BROAD-SPECTRUM NEUTRALIZING EPITOPES IN THE SPIKE PROTEIN OF SARS-COV-2 PREDICTED BY BIOINFORMATICS
    He, Yunyi
    Zhang, Ning
    Qu, Ying
    Zhu, Hanyu
    Liu, Qiliang
    Liu, Hongbo
    ACTA MEDICA MEDITERRANEA, 2021, 37 (03): : 1323 - 1329
  • [2] SARS-CoV-2 variants of concern: spike protein mutational analysis and epitope for broad neutralization
    Mannar, Dhiraj
    Saville, James W.
    Sun, Zehua
    Zhu, Xing
    Marti, Michelle M.
    Srivastava, Shanti S.
    Berezuk, Alison M.
    Zhou, Steven
    Tuttle, Katharine S.
    Sobolewski, Michele D.
    Kim, Andrew
    Treat, Benjamin R.
    Castanha, Priscila Mayrelle Da Silva
    Jacobs, Jana L.
    Barratt-Boyes, Simon M.
    Mellors, John W.
    Dimitrov, Dimiter S.
    Li, Wei
    Subramaniam, Sriram
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [3] Structural Study of SARS-CoV-2 Antibodies Identifies a Broad-Spectrum Antibody That Neutralizes the Omicron Variant by Disassembling the Spike Trimer
    Zhan, Wuqiang
    Tian, Xiaolong
    Zhang, Xiang
    Xing, Shenghui
    Song, Wenping
    Liu, Qianying
    Hao, Aihua
    Hu, Yuxia
    Zhang, Meng
    Ying, Tianlei
    Chen, Zhenguo
    Lan, Fei
    Sun, Lei
    JOURNAL OF VIROLOGY, 2022, 96 (16)
  • [4] Structure of SARS-CoV-2 spike protein
    Zhang, Jun
    Xiao, Tianshu
    Cai, Yongfei
    Chen, Bing
    CURRENT OPINION IN VIROLOGY, 2021, 50 : 173 - 182
  • [5] Development of Broad-Spectrum Nanobodies for the Therapy and Diagnosis of SARS-CoV-2 and Its Multiple Variants
    He, Lei
    Wu, Qian
    Zhang, Zhaoyong
    Chen, Lingling
    Yu, Kuai
    Li, Leibin
    Jia, Qiong
    Wang, Yanqun
    Ni, Jianqiang
    Wang, Chuanbin
    Li, Qi
    Zhai, Xinyan
    Zhao, Jincun
    Liu, Yuliang
    Fan, Ruiwen
    Li, Yi-Ping
    MOLECULAR PHARMACEUTICS, 2024, 21 (08) : 3866 - 3879
  • [6] A thermostable, closed SARS-CoV-2 spike protein trimer
    Xiong, Xiaoli
    Qu, Kun
    Ciazynska, Katarzyna A.
    Hosmillo, Myra
    Carter, Andrew P.
    Ebrahimi, Soraya
    Ke, Zunlong
    Scheres, Sjors H. W.
    Bergamaschi, Laura
    Grice, Guinevere L.
    Zhang, Ying
    Nathan, James A.
    Baker, Stephen
    James, Leo C.
    Baxendale, Helen E.
    Goodfellow, Ian
    Doffinger, Rainer
    Briggs, John A. G.
    Bradley, John
    Lyons, Paul A.
    Smith, Kenneth G. C.
    Toshner, Mark
    Elmer, Anne
    Ribeiro, Carla
    Kourampa, Jenny
    Jose, Sherly
    Kennet, Jane
    Rowlands, Jane
    Meadows, Anne
    O'Brien, Criona
    Rastall, Rebecca
    Crucusio, Cherry
    Hewitt, Sarah
    Price, Jane
    Calder, Jo
    Canna, Laura
    Bucke, Ashlea
    Tordesillas, Hugo
    Harris, Julie
    Ruffolo, Valentina
    Domingo, Jason
    Graves, Barbara
    Butcher, Helen
    Caputo, Daniela
    Le Gresley, Emma
    Dunmore, Benjamin J.
    Martin, Jennifer
    Legchenko, Ekaterina
    Treacy, Carmen
    Huang, Christopher
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2020, 27 (10) : 934 - +
  • [7] The α-dystroglycan N-terminus is a broad-spectrum antiviral agent against SARS-CoV-2 and enveloped viruses
    Bigotti, Maria Giulia
    Klein, Katja
    Gan, Esther S.
    Anastasina, Maria
    Andersson, Simon
    Vapalahti, Olli
    Katajisto, Pekka
    Erdmann, Maximilian
    Davidson, Andrew D.
    Butcher, Sarah J.
    Collinson, Ian
    Ooi, Eng Eong
    Balistreri, Giuseppe
    Brancaccio, Andrea
    Yamauchi, Yohei
    ANTIVIRAL RESEARCH, 2024, 224
  • [8] Recombinant protein HR212 targeting heptad repeat 2 domain in spike protein S2 subunit elicits broad-spectrum neutralizing antibodies against SARS-CoV-2 and its variants
    Lu, Ying
    Li, An-Qi
    Shen, Fan
    He, Wen-Qiang
    Yu, Shu-Heng
    Zhao, Yan-Bo
    Feng, Xiao-Li
    Li, Ming-Hua
    Ouyang, Songying
    Zheng, Yong-Tang
    Pang, Wei
    MEDCOMM, 2025, 6 (02):
  • [9] Ultralarge Virtual Screening Identifies SARS-CoV-2 Main Protease Inhibitors with Broad-Spectrum Activity against Coronaviruses
    Luttens, Andreas
    Gullberg, Hjalmar
    Abdurakhmanov, Eldar
    Duy Duc Vo
    Akaberi, Dario
    Talibov, Vladimir O.
    Nekhotiaeva, Natalia
    Vangeel, Laura
    De Jonghe, Steven
    Jochmans, Dirk
    Krambrich, Janina
    Tas, Ali
    Lundgren, Bo
    Gravenfors, Ylva
    Craig, Alexander J.
    Atilaw, Yoseph
    Sandstrom, Anja
    Moodie, Lindon W. K.
    Lundkvist, Ake
    van Hemert, Martijn J.
    Neyts, Johan
    Lennerstrand, Johan
    Kihlberg, Jan
    Sandberg, Kristian
    Danielson, U. Helena
    Carlsson, Jens
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2022, 144 (07) : 2905 - 2920
  • [10] Mapping cross-variant neutralizing sites on the SARS-CoV-2 spike protein
    Xu, Shiqi
    Wang, Yifan
    Wang, Yanxing
    Zhang, Chao
    Hong, Qin
    Gu, Chenjian
    Xu, Rong
    Wang, Tingfeng
    Yang, Yong
    Zang, Jinkai
    Zhou, Yu
    Li, Zuyang
    Liu, Qixing
    Zhou, Bingjie
    Bai, Lulu
    Zhu, Yuanfei
    Deng, Qiang
    Wang, Haikun
    Lavillette, Dimitri
    Wong, Gary
    Xie, Youhua
    Cong, Yao
    Huang, Zhong
    EMERGING MICROBES & INFECTIONS, 2022, 11 (01) : 351 - 367